These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18036989)

  • 1. Immunoadsorption in dilated cardiomyopathy.
    Staudt A; Felix SB
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
    Felix SB; Staudt A
    Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies.
    Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A
    Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in dilated cardiomyopathy.
    Felix SB
    Ernst Schering Res Found Workshop; 2006; (55):353-61. PubMed ID: 16329672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
    Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ
    Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy.
    Felix SB; Staudt A; Friedrich GB
    Autoimmunity; 2001; 34(3):211-5. PubMed ID: 11908780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR; Felix SB; Staudt A
    Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.
    Jahns R; Boivin V; Lohse MJ
    Trends Cardiovasc Med; 2006 Jan; 16(1):20-4. PubMed ID: 16387626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antibodies obtained from patients with dilated cardiomyopathy on the function of isolated rat hearts.
    Staudt Y; Trimpert C; Birkenmeier K; Krieg T; Bemmann T; Beug D; Felix SB; Staudt A
    Eur J Clin Invest; 2006 Feb; 36(2):85-90. PubMed ID: 16436089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
    Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
    Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption therapy in dilated cardiomyopathy.
    Felix SB; Beug D; Dörr M
    Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):145-52. PubMed ID: 25494978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M; Wallukat G; Englert A; Hetzer R
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
    Mobini R; Maschke H; Waagstein F
    Autoimmun Rev; 2004 Jun; 3(4):277-84. PubMed ID: 15246023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.